By Iris Kulbatski — 2020
Psychedelic drugs like psilocybin are being tested to treat mental illness. They're also expanding our understanding about human consciousness.
Read on www.discovermagazine.com
CLEAR ALL
In 2008, Eben Alexander, MD, an academic neurosurgeon for over twenty-five years, fell into a deep coma.
Some of the health risks of inhaling fine and ultrafine particles are well-established, such as asthma, lung cancer, and, most recently, heart disease.
Ahead of a big science conference in Northern California, we speak with Dr. Dean Radin, who after years of study came to believe that there might be something to psi phenomena.
The emerging field of “neuropsychoanalysis” aims to combine two fundamentally different areas of study—psychoanalysis and neuroscience—for a whole new way of understanding how the mind works.
The Food and Drug Administration (FDA) has approved the design of two Phase 3 clinical trials of MDMA for treating PTSD, according to the Multidisciplinary Association for Psychedelic Studies (MAPS), which is funding and leading the clinical trials.
1
The world’s leading advocate for the medicinal use of psychedelics on the ghost of Timothy Leary, why Ecstasy could cure PTSD, and the best place to trip in Boston.
Psychics and psychosis sufferers alike hold beliefs that may predispose them to hearing voices.
Hypnosis has become a common medical tool, used to reduce pain, help people stop smoking and cure them of phobias. But scientists have long argued about whether the hypnotic “trance” is a separate neurophysiological state or simply a product of a hypnotized person’s expectations.
Studies confirm that during hypnosis subjects are not in a sleeplike state but are awake.
Psychedelic drugs—once promising research subjects that were decades ago relegated to illicit experimentation in dorm rooms—have been steadily making their way back into the lab for a revamped 21st-century-style look.